Allogeneic stem cell transplantation for advanced cutaneous T-cell lymphomas: a study from the French Society of Bone Marrow Transplantation and French Study Group on Cutaneous Lymphomas
de Masson, Adele; Beylot-Barry, Marie; Bouaziz, Jean-Davidet al.
de Masson, Adele; Université Paris VII Sorbonne Paris Cité > AP-HP > Service de Dermatologie
Beylot-Barry, Marie; Université Bordeaux II, France > CHU de Bordeaux > Service de Dermatologie
Bouaziz, Jean-David; Université Paris VII Sorbonne Paris Cité > AP-HP > Service de Dermatologie
Peffault de Latour, Régis; Université Paris VII Sorbonne Paris Cité > AP-HP > Service d’Hématologie-Greffe
Aubin, Francois; CHU de Besançon, Besançon, France > Service de Dermatologie
Garciaz, Sylvain; Institut Paoli-Calmettes, Marseille, France > Service d’Hématologie
d’Incan, Michel; CHU Estaing, Clermont-Ferrand, France > Service de Dermatologie,
Dereure, Olivier; CHU Saint-Eloi, Montpellier, France > Service de Dermatologie
Dalle, Stéphane; Université Claude Bernard Lyon, Lyon, France > Centre de recherche en Cancérologie de Lyon, Hospices Civils de Lyon, > Service de Dermatologie
Dompmartin, Anne; CHU de Caen, Caen, France > Service de Dermatologie
Suarez, Felipe; CHU Necker-Enfants Malades, Paris, France > Service d’Hématologie
Battistella, Maxime; Hôpital Saint-Louis, Paris, France > Laboratoire de Pathologie
Vignon-Pennamen, Marie-Dominique; Hôpital Saint-Louis, Paris, France > Laboratoire de Pathologie,
Rivet, Jacqueline; Hôpital Saint-Louis, Paris, France > Laboratoire de Pathologie
Adamski, Henri; CHU Pontchaillou, Rennes, France > Service de Dermatologie,
Brice, Pauline; CHU Saint-Louis, Paris, France > Service d’Hématologie-Oncologie
Sylvie, Francois; CHU d’Angers, Angers, France > Service des Maladies du Sang
Lissandre, Séverine; CHU de Tours, Tours, France > Service d’Hématologie,
Turlure, Pascal; CHU de Limoges, Limoges, France > Service d’Hématologie
Wierzbicka-Hainaut17,, Ewa; CHU de Poitiers, Poitiers, France > Service de Dermatologie,
Brissot, Eolia; CHU de Nantes, Nantes, France > Service d’Hématologie,
Dulery, Rémy; CHRU Claude Huriez, Lille, France > Service d’Hématologie clinique
SERVAIS, Sophie ; Centre Hospitalier Universitaire de Liège - CHU > Hématologie clinique
Ravinet, Aurélie; CHU Estaing, Clermont-Ferrand, France > Service d’Hématologie Adultes,
Tabriz, Reza; CHU de Bordeaux, Bordeaux, France > Hôpital Haut-Lévèque > Service d'Hématologie,
Ingen-Housz-Oro, Saskia; CHU Henri-Mondor, Créteil, France > Service de Dermatologie,
Joly, Pascal; CHU Charles-Nicolle, Rouen, France > Service de Dermatologie,
Socie, Gerard; Université Paris VII Sorbonne Paris Cité, Unité > AP-HP, > Service d’Hématologie-Greffe,
Bagot, Martine; Université Paris VII Sorbonne Paris Cité, Unité INSERM > AP-HP > Service de Dermatologie
Allogeneic stem cell transplantation for advanced cutaneous T-cell lymphomas: a study from the French Society of Bone Marrow Transplantation and French Study Group on Cutaneous Lymphomas
Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105(10):3768-85.
Olsen E, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R, et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood. 2007;110(6):1713-22.
Agar NS, Wedgeworth E, Crichton S, Mitchell TJ, Cox M, Ferreira S, et al. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal. J Clin Oncol. 2010;28(31):4730-9.
Vergier B, de Muret A, Beylot-Barry M, Vaillant L, Ekouevi D, Chene G, et al. Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneious Lymphomas. Blood. 2000;95 (7):2212-8.
Arulogun SO, Prince HM, Ng J, Lade S, Ryan GF, Blewitt O, et al. Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation. Blood. 2008;112(8):3082-7.
Ingen-Housz-Oro S, Bachelez H, Verola O, Lebbé C, Marolleau JP, Hennequin C, et al. High-dose therapy and autologous stem cell transplantation in relapsing cutaneous lymphoma. Bone Marrow Transplant. 2004;33(6):629-34.
Bekkenk MW, Geelen FA, van Voorst Vader PC, Heule F, Geerts ML, van Vloten WA, et al. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood. 2000;95(12):3653-61.
Herbert KE, Spencer A, Grigg A, Ryan G, McCormack C, Prince HM. Graft-versuslymphoma effect in refractory cutaneous Tcell lymphoma after reduced-intensity HLA-matched sibling allogeneic stem cell transplantation. Bone Marrow Transplant. 2004;34(6):521-5.
Molina A, Zain J, Arber DA, Angelopolou M, O'Donnell M, Murata-Collins J, et al. Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoides. J Clin Oncol. 2005;23(25):6163-71.
Duvic M, Donato M, Dabaja B, Richmond H, Singh L, Wei W, et al. Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome. J Clin Oncol. 2010;28(14):2365-72.
Duarte RF, Canals C, Onida F, Gabriel IH, Arranz R, Arcese W, et al. Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol. 2010;28(29):4492-9.
Duarte RF, Schmitz N, Servitje O, Sureda A. Haematopoietic stem cell transplantation for patients with primary cutaneous T-cell lymphoma. Bone Marrow Transplant. 2008;41(7):597-604.
Paralkar VR, Nasta SD, Morrissey K, Smith J, Vassilev P, Martin ME, et al. Allogeneic hematopoietic SCT for primary cutaneous T cell lymphomas. Bone Marrow Transplant. 2012;47(7):940-5.
Carrié E, Buzyn A, Fraitag S, Hermine O, Bodemer C. [Transformed juvenile-onset mycosis fungoides: treatment by bone marrow transplantation with graft-versus-lymphoma effect]. Ann Dermatol Venereol. 2007;134(5 Pt 1):471-6.
Terras S, Moritz RKC, Ditschkowski M, Beelen DW, Altmeyer P, Stücker M, et al. Allogeneic Haematopoietic Stem Cell Transplantation in a Patient with Cutaneous γ/δ-T-cell Lymphoma. Acta Derm Venereol. 2013;93(3):360-1.
Yuan L, Sun L, Bo J, Zhou Y, Li H, Yu L, et al. Durable remission in a patient with refractory subcutaneous panniculitis-like Tcell lymphoma relapse after allogeneic hematopoietic stem cell transplantation through withdrawal of cyclosporine. Ann Transplant. 2011;16(3):135-8.
Pérez-Persona E, Mateos-Mazón JJ, López-Villar O, Arcos MJ, Encinas C, Graciani IF, et al. Complete remission of subcutaneous panniculitic T-cell lymphoma after allogeneic transplantation. Bone Marrow Transplant. 2006;38(12):821-2.
Fijnheer R, Sanders CJG, Canninga MR, de Weger RA, Verdonck LF. Complete remission of a radiochemotherapy-resistant cutaneous T-cell lymphoma with allogeneic non-myeloablative stem cell transplantation. Bone Marrow Transplant. 2003;32(3):345-7.
Ohmatsu H, Sugaya M, Fujita H, Kadono T, Sato S. Primary Cutaneous Follicular Helper T-cell Lymphoma Treated with Allogeneic Bone Marrow Transplantation: Immunohistochemical Comparison with Angioimmunoblastic T-cell Lymphoma. Acta Derm Venereol. 2013 June 5 [Epub ahead of print].
Kim YH, Willemze R, Pimpinelli N, Whittaker S, Olsen EA, Ranki A, et al. TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC). Blood. 2007;110(2):479-84.
Poszepczynska-Guigné E, Schiavon V, D'Incan M, Echchakir H, Musette P, Ortonne N, et al. CD158k/KIR3DL2 is a new phenotypic marker of Sezary cells: relevance for the diagnosis and follow-up of Sezary syndrome. J Invest Dermatol. 2004; 122(3):820-3.
Bouaziz J-D, Remtoula N, Bensussan A, Marie-Cardine A, Bagot M. Absolute CD3+ CD158k+ lymphocyte count is reliable and more sensitive than cytomorphology to evaluate blood tumour burden in Sézary syndrome. Br J Dermatol. 2010;162(1):123-8.
Bensussan A, Remtoula N, Sivori S, Bagot M, Moretta A, Marie-Cardine A. Expression and function of the natural cytotoxicity receptor NKp46 on circulating malignant CD4+ T lymphocytes of Sézary syndrome patients. J Invest Dermatol. 2011;131(4):969-76.
Olsen EA, Whittaker S, Kim YH, Duvic M, Prince HM, Lessin SR, et al. Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. J Clin Oncol. 2011;29(18):2598-607.
Scrucca L, Santucci A, Aversa F. Competing risk analysis using R: an easy guide for clinicians. Bone Marrow Transplant. 2007; 40(4):381-7.
Dummer R, Quaglino P, Becker JC, Hasan B, Karrasch M, Whittaker S, et al. Prospective international multicenter phase II trial of intravenous pegylated liposomal doxorubicin monochemotherapy in patients with stage IIB, IVA, or IVB advanced mycosis fungoides: final results from EORTC 21012. J Clin Oncol. 2012;30 (33):4091-7.
Storb R, Gyurkocza B, Storer BE, Sorror ML, Blume K, Niederwieser D, et al. Graftversus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation. J Clin Oncol. 2013;31(12): 1530-8.
